These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28783379)

  • 41. Microfluidics for Single-Cell Study of Antibiotic Tolerance and Persistence Induced by Nutrient Limitation.
    Moreno-Gámez S; Dal Co A; van Vliet S; Ackermann M
    Methods Mol Biol; 2021; 2357():107-124. PubMed ID: 34590255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tolerance and heteroresistance in Gram-positive microorganisms].
    Morosini MI; Cantón R
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():16-22. PubMed ID: 21477700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxin-antitoxin systems and their role in disseminating and maintaining antimicrobial resistance.
    Yang QE; Walsh TR
    FEMS Microbiol Rev; 2017 May; 41(3):343-353. PubMed ID: 28449040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic resistance and bacterial biofilm.
    Grande R; Puca V; Muraro R
    Expert Opin Ther Pat; 2020 Dec; 30(12):897-900. PubMed ID: 32985275
    [No Abstract]   [Full Text] [Related]  

  • 45. Phenotypic heterogeneity in persisters: a novel 'hunker' theory of persistence.
    Urbaniec J; Xu Y; Hu Y; Hingley-Wilson S; McFadden J
    FEMS Microbiol Rev; 2022 Jan; 46(1):. PubMed ID: 34355746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of toxin-antitoxin modules in Burkholderia cenocepacia biofilm persistence.
    Van Acker H; Sass A; Dhondt I; Nelis HJ; Coenye T
    Pathog Dis; 2014 Aug; 71(3):326-35. PubMed ID: 24719230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secondary multidrug efflux pump mutants alter Escherichia coli biofilm growth in the presence of cationic antimicrobial compounds.
    Bay DC; Stremick CA; Slipski CJ; Turner RJ
    Res Microbiol; 2017 Apr; 168(3):208-221. PubMed ID: 27884783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delicate Metabolic Control and Coordinated Stress Response Critically Determine Antifungal Tolerance of Candida albicans Biofilm Persisters.
    Li P; Seneviratne CJ; Alpi E; Vizcaino JA; Jin L
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6101-12. PubMed ID: 26195524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persisters: a distinct physiological state of E. coli.
    Shah D; Zhang Z; Khodursky A; Kaldalu N; Kurg K; Lewis K
    BMC Microbiol; 2006 Jun; 6():53. PubMed ID: 16768798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P; Allison DG; McBain AJ
    Symp Ser Soc Appl Microbiol; 2002; (31):98S-110S. PubMed ID: 12481835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aminoglycoside antibiotics induce bacterial biofilm formation.
    Hoffman LR; D'Argenio DA; MacCoss MJ; Zhang Z; Jones RA; Miller SI
    Nature; 2005 Aug; 436(7054):1171-5. PubMed ID: 16121184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic and genetic changes in the life cycle of small colony variants of Salmonella enterica serotype Typhimurium induced by streptomycin.
    Li W; Li Y; Wu Y; Cui Y; Liu Y; Shi X; Zhang Q; Chen Q; Sun Q; Hu Q
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):37. PubMed ID: 27245674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
    Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
    Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persisters: Methods for Isolation and Identifying Contributing Factors--A Review.
    Rowe SE; Conlon BP; Keren I; Lewis K
    Methods Mol Biol; 2016; 1333():17-28. PubMed ID: 26468096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial peptides as potential tool to fight bacterial biofilm.
    Dawgul M; Maciejewska M; Jaskiewicz M; Karafova A; Kamysz W
    Acta Pol Pharm; 2014; 71(1):39-47. PubMed ID: 24779193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting Antibiotic Tolerance, Pathogen by Pathogen.
    Meylan S; Andrews IW; Collins JJ
    Cell; 2018 Mar; 172(6):1228-1238. PubMed ID: 29522744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel approaches to combat bacterial biofilms.
    Beloin C; Renard S; Ghigo JM; Lebeaux D
    Curr Opin Pharmacol; 2014 Oct; 18():61-8. PubMed ID: 25254624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biofilms: Microbial Shelters Against Antibiotics.
    Hathroubi S; Mekni MA; Domenico P; Nguyen D; Jacques M
    Microb Drug Resist; 2017 Mar; 23(2):147-156. PubMed ID: 27214143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concepts in disinfection of bacterial populations.
    Cogan NG
    Math Biosci; 2013 Oct; 245(2):111-25. PubMed ID: 23891584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.